Journal
SOUTHERN MEDICAL JOURNAL
Volume 115, Issue 4, Pages 266-269Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.14423/SMJ.0000000000001379
Keywords
autoimmune myopathy; myopathy; statin-induced autoimmune myopathy; statins
Categories
Ask authors/readers for more resources
This case study presents a 61-year-old male with rhabdomyolysis attributed to the recent initiation of statin therapy. Despite aggressive fluid resuscitation, the patient showed persistent myalgias and progressive weakness. After ruling out other causes, the diagnosis of statin-induced necrotizing autoimmune myopathy was made based on muscle biopsy findings. The patient improved with immunosuppressive therapy.
We present the case of a 61-year-old male with hyperlipidemia and lumbar radiculopathy admitted to our hospital with rhabdomyolysis attributed to the recent initiation of statin therapy. Despite aggressive fluid resuscitation and an initial declination in his creatine phosphokinase (CPK) levels, he had persistent myalgias with progressive weakness. Rheumatologic and neurologic evaluation for other causes of myopathy were negative. Muscle biopsy obtained showed signs of necrosis and muscle regeneration. Given his recent statin use, persistent CPK elevation, proximal muscle weakness, and muscle biopsy findings, he was diagnosed as having statin-induced necrotizing autoimmune myopathy. He improved with the initiation of immunosuppressive therapy. Statin-induced necrotizing autoimmune myopathy is an underdiagnosed cause of myalgias, proximal muscle weakness, and significant CPK elevation that fails to respond to statin discontinuation and fluid resuscitation. Given the prevalence of statin use, internists need to have a high index of suspicion for this diagnosis in patients presenting with CPK elevations and muscle weakness who take statin therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available